Nu-Med Plus, Inc. (NUMD) Stock

About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.

Nu-Med Plus, Inc. is headquartered in US.

Nu-Med Plus, Inc. (NUMD) stock trades at $0.02 with a market capitalization of $1.54M. The stock is valued at a price-to-earnings (P/E) ratio of -30.67, price-to-book of -5.35, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.05, and currently trades 60.0% below its 52-week high.

On profitability, Nu-Med Plus, Inc. generates a return on equity (ROE) of 19.60%, above the typical market average, return on capital employed of 15.12%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.nu-medplus.com